Clinical Trial Update: Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) [Phase 1]

View source ↗

Summary

Phase 1b long-term extension trial of RAY121 in multiple immunological diseases is currently enrolling by invitation, expanding early-phase evaluation across se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Behçet Disease
• Bullous Pemphigoid
• Dermatomyositis
• Immune Thrombocytopenia
• Immune-mediated Necrotizing Myopathy

Drugs mentioned

• RAY121

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP) | Phase 1 | Status: ENROLLING_BY_INVITATION